Clinical Profile of Dengue Infection in Patients with Hematological Diseases by Sharma, Sanjeev Kumar et al.
Mediterr J Hematol Infect Dis 2011; 3; Open Journal System 
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
Original Articles  
Clinical Profile of Dengue Infection in Patients with Hematological Diseases
Sanjeev  Kumar  Sharma
1,  Tulika  Seth
Mahapatra
1 and Renu Saxena
1
1Department of Hematology and 
2Microbiology, 
Correspondence to:  Dr. Pravas  Mishra,  MD,  DM.  Department  of  Hematology,  All  India  Institute  of  Medical 
Sciences, New Delhi, India. Tel: 91-11-
Competing interests: The authors have declared th
Published: September 8, 2011
Received: June16, 2011
Accepted: July 29, 2011
Mediterr J Hematol  Infect Dis 2011, 3: e201
This article is available from: http://www.mjhid.org/article/view/8933
This  is  an  Open  Access  article  distributed  under  the  terms  of  the  Creative  Commons  Attribution  License
(http://creativecommons.org/licenses/by/2.0
provided the original work is properly cited
   
Abstract:  Managing  hematological  disorders  in  a  tropical  country  presents  several  unique 
diagnostic and management problems. Apart from the disease process, we need to be aware of 
infections that can exacerbate or mimic serious hematological problems. We present here a series of 
five patients with pre-existing hematological diseases who were infected by dengue virus. These 
cases  highlight  the  need  to  keep  a  strong  suspicion  of  common  endemic  diseases  in  tropical 
countries before considering extensive workup for the basic hematolog
mortality  and  all  patients  recovered  without  any  significant  impact  on  their  pre
hematological condition inspite of their low baseline blood counts. There was no excessive bleeding, 
prolonged stay in the hospital or rela
the only major concern was the increased anxiety among both the patient and treating physician 
regarding the relapse/progression of pre
Introduction: Patients with pre-existing hematological 
diseases are equally at risk of acquiring vector
infections as is the general population. The impact of 
dengue  infection  on  the  hematological  patients  has  
been rarely studied.  Dengue  infection  causes 
leucopenia  and  thrombocytopenia  and  may  mimic 
relapse or progression of an underlying hematological 
disease. Dengue virus infection has never been looked 
into  seriously  in  hematological  patients.  We  had  a 
dengue  epidemic  in  the  months  of  September  to 
November 2010 in New Delhi, India. This epidemic of 
dengue infection gave us the opportunity to study the 
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ological  disorders  in  a  tropical  country  presents  several  unique 
diagnostic and management problems. Apart from the disease process, we need to be aware of 
infections that can exacerbate or mimic serious hematological problems. We present here a series of 
existing hematological diseases who were infected by dengue virus. These 
cases  highlight  the  need  to  keep  a  strong  suspicion  of  common  endemic  diseases  in  tropical 
countries before considering extensive workup for the basic hematological disease. There was no 
mortality  and  all  patients  recovered  without  any  significant  impact  on  their  pre
hematological condition inspite of their low baseline blood counts. There was no excessive bleeding, 
prolonged stay in the hospital or relapse of underlying hematological disease in these patients and 
the only major concern was the increased anxiety among both the patient and treating physician 
regarding the relapse/progression of pre-existing hematological disease.
existing hematological 
diseases are equally at risk of acquiring vector-borne 
infections as is the general population. The impact of 
hematological  patients  has  
studied.  Dengue  infection  causes 
leucopenia  and  thrombocytopenia  and  may  mimic 
relapse or progression of an underlying hematological 
disease. Dengue virus infection has never been looked 
al  patients.  We  had  a 
dengue  epidemic  in  the  months  of  September  to 
November 2010 in New Delhi, India. This epidemic of 
dengue infection gave us the opportunity to study the 
impact  of  dengue  in  patients  with  pre
hematological diseases.  All these 
us at a time when dengue infection was rampant in the 
community. 
Case series
Case  1: A  4-year-old  child,  who  had  undergone  a 
sibling  matched  allogeneic  bone  marrow  transplant 
(BMT)  for  chronic  myeloid  leukemia
(CML-BC), presented to the emergency on day 180 of 
her transplant with high grade fever and bodyache
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old  child,  who  had  undergone  a 
sibling  matched  allogeneic  bone  marrow  transplant 
(BMT)  for  chronic  myeloid  leukemia-blast  crises 
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3 days and bleeding from nose for 1 day. Hemogram 
revealed low counts [hemoglobin (Hb) 10.6g/dl, total 
leukocyte  count  (TLC)  2.2x10
9/l  with  differential 
count: neutrophils 42%, lymphocytes 48%, monocytes 
8%, eosinophils 2% with no atypical cells, and platelet 
count  10x10
9/l].    Relapse,  graft  rejection  and  sepsis 
were  all  considered  as  the  cause  of  decreasing 
leukocyte  and platelet counts in this post BMT patient. 
Chimerism was 100% a month back. There were no 
blasts  in  the  peripheral  smear  and  the  bone  marrow 
examination was normal. Blood cultures were sterile 
and  a  computerised  tomography  scan  of  chest  and 
abdomen did not reveal any focus of infection. Broad 
spectrum  antibiotics  were  started  as  per  institutional 
policy  for  such  patients  and  her  general  condition 
improved  even  though  counts  remained  low.  A 
quantitative  polymerase  chain  reaction  (PCR)  for 
cytomegalovirus (CMV) was negative. The mu-capture 
enzyme  linked  immunosorbent  assay  (ELISA)  for 
dengue IgM was positive and the child was managed 
conservatively  with  platelet  transfusions.  The  counts 
recovered by day 9 after first onset of symptoms. 
Case  2: A  10-year-old  child,  a  case  of  immune 
thrombocytopenic purpura (ITP) on low dose steroids 
was maintaining his platelet counts at around 50 x10
9/l, 
when he developed fever and petechial rash of 5 days 
duration  with  fall  in  platelets  to  20x10
9/l.  With  the 
previous case in mind and before considering change in 
treatment for ITP, dengue NS-1 antigen and later mu-
capture ELISA  for  dengue IgM were  performed  and 
found  to  be  positive.  He  was  treated  conservatively 
with intravenous fluids and antipyretics. Platelet counts 
started increasing on 7
th day of illness.  The steroids 
were  not  stopped  during  this  episode  of  fever.  In 
patients  of  ITP  presenting  with  fever  and  falling 
platelet  counts  for  any  reason,  we  even  consider 
increasing the dose of steroids along with therapy for 
fever  in  case  of  bleeding  or  platelet  counts  below 
20x10
9/l. In this patient we continued with the same 
dose as platelets did not fall below 20x10
9/l and the 
child did not have any evidence of serious bleed except 
for petechiae.
Case 3:  A 35-year-old lady on maintenance therapy 
for  acute  promyelocytic  leukemia  (APL),  developed 
high  grade  fever  and  petechial  rash  over  limbs  and 
bleeding from gums for  3 days. She had features of 
generalised bodyaches and malaise for a week prior to
fever. Hemogram revealed Hb 11.2g%, TLC 4.8 x 10
9/l 
with  normal  differential  count  and  no  atypical  cells, 
and  platelet  count  8  x10
9/l.  Prothrombin  time    (test 
12secs  and  control  13secs)  and  activated  partial 
thromboplastin time  (test  32secs  and  control 30secs) 
were  normal.  Pateint  received  antibiotics  and  single 
donor platelet transfusions to maintain platelet counts 
above 20 x10
9/l.  The mu-capture ELISA for dengue 
IgM was positive. Her platelet counts increased over 
the  next  10  days  to  more  than  150  x  10
9/l.    Bone 
marrow examination was not done as patient showed 
symptomatic improvement and there was no evidence 
of  APL  relapse  on  peripheral  smear.  However,  a 
subsequent  marrow  aspirate  done  to  document 
molecular response as per protocol confirmed absence 
of disease.
Case  4: A  50-year-old  gentleman,  a  case  of 
autoimmune  hemolytic  anemia  (AIHA)  diagnosed  in 
2007,  was  off  steroids  for  the  last  two  years  and 
maintained hemoglobin levels between 8 to 10g/dl. He 
developed high grade fever with bodyaches for 1 week. 
Hemogram  revealed  Hb  7.4g/dl,  TLC  3.3x10
9/l  and 
platelet  count  40x10
9/l.  Workup  for  fever  revealed 
positive dengue serology (IgM) by ELISA. There were 
no bleeding manifestations. Platelet counts increased to 
more than 150x 10
9/l by 6
th day. 
Case  5: An  8-years-old  child,  a  case  of thalassemia 
major,  who  had  undergone  a  successful  sibling 
matched  allogeneic  BMT  presented  on  day  70  of 
transplant  with  high  grade  fever  of  1  day  duration. 
Hemogram  showed  Hb  8.1g/dl,  TLC  1.4  x10
9/l  and 
platelet count 26 x10
9/l. Mu-capture ELISA for dengue 
IgM on day 8 of admission was positive. The child’s 
fever subsided after 2 days but the counts continued to 
drop till day 5 of admission after which they started to 
rise. 
Results:  All  of  these  patients  presented  with  high 
grade fever and thrombocytopenia, though only three 
patients had bleeding manifestations. Leucopenia was 
also present in three of these patients. Other complaints 
were bodyaches and retro-orbital pain (Table 1). 
All  these  patients  had  dengue  IgM  positive  by 
ELISA implying that inspite of being affected by pre-
existing  hematological  diseases/immunodeficientMediterr J Hematol Infect Dis 2011; 3: Open Journal System
Table 1: Characteristics of dengue infected patients with pre-existing hematological diseases.
CML-BC- chronic  myeloid  leukemia-blast crises, BMT-bone marrow transplant,  ITP-idiopathic thrombocytopenic purpura, APL- acute 
promyelocytic leukemia, AIHA-autoimmune hemolytic anemia, Thal- thalassemia.
conditions they were able to mount antibody response 
to dengue virus (Table 2), though dengue IgG was not 
evaluated  prospectively.  Serotyping  revealed  dengue 
virus type 1 by PCR and culture in all five cases. Four 
of  our  five  patients  with  dengue  fever  received 
inpatient  treatment  with  intravenous  fluids  and/or 
platelet transfusion and one patient (with AIHA) was 
managed on outpatient basis. 
None  of  the  patients  developed  dengue  shock 
syndrome  or  significant  bleeding.  There  was  no 
mortality in spite of severe thrombocytopenias in some 
of these cases implying that pre-existing hematological 
diseases  do  not  put  such  patients  at  higher  risk  of 
morbidity or mortality if they contract dengue.
Discussion:  Dengue  is  one  of  the  most  common 
mosquito-borne  infectious  diseases  prevalent  in 
tropical  countries.  It  has  been  a  major  public  health 
problem causing significant morbidity and mortality in 
the  general  population.  In  patients  with  pre-existing 
hematological  diseases,  dengue  infection  can  pose  a 
major diagnostic challenge because of similar clinical 
presentations with fever and cytopenias. Patients with 
hematological  diseases  like  idiopathic 
thrombocytopenic  purpura,  leukemias  and  transplant 
recipients are equally vulnerable to dengue. There is no 
data on the impact of dengue in immunocompromised 
patients and those with hematological diseases, baring 
a few case reports.
1,2
Dengue fever is caused by a positive single stranded 
RNA virus of the flaviviridae family. It is spread by 
Aedes  mosquitoes  (Aedes  aegyti  and  Aedes 
albopictus).  Leukopenia,  thrombocytopenia,  and 
hemorrhagic  diathesis  are  the  charasteristic 
hematologic  findings  in  dengue  virus  infection. 
Leukopenia appears early in the course of illness and is 
thought to occur as a direct effect of dengue virus on 
the  bone  marrow.
3 Dengue  also  causes  a  transient 
decrease  in  maturation  of  erythroid  precursors,
4
however because of the long half life of the red cells, 
dengue  does  not  cause  severe  anemia  in  infected 
individuals.  Cause  of  thrombocytopenia  is 
multifactorial.  Both  bone  marrow  suppression  and
platelet  destruction  contribute  to  thrombocytopenia,
with later playing more important role.
5 Generation of 
virus-antibody  immune  complexes,  leading  to
complement activation, is considered to be responsible 
for  the  platelet  destruction.
6,7  In  patients  with  pre-
existing  hematological  diseases  the  bone  marrow 
reserve in already compromised and any further insult
to hematopoeitic cells may have serious consequences. 
However,  when  we  observed  our  patients
Table 2: Salient features observed in hematological patients infected with dengue virus.
-    Clinical features were similar to those usually seen in patients without pre-existing hematological diseases
-    Dengue serology was positive in all cases and was not affected by underlying immunocompromised state.
-    A strong clinical suspicion averted the need for unnecessary and costlier investigations.
-    There was complete recovery of counts to baseline with supportive treatment.
Case 
No.
Age 
(yrs)
Hematological 
disease
Clinical 
presentation Diagnostic test
Lowest 
platelet 
count
Lowest TLC 
count
Platelet 
transfusion
Time to 
clinical 
recovery
1 4 CML-BC post 
BMT Fever, epistaxis IgM positive 10x10
9/l 2.2x10
9/l required 9 days
2 10 ITP Fever, petechiae NS-1 & IgM 
positive 20x10
9/l 4.6x10
9/l not required 7 days
3 35 APL Fever, gum bleed IgM positive 8x10
9/l 4.8x10
9/l required 10 days
4 50 AIHA Fever, bodyaches IgM positive 40x10
9/l 3.3x10
9/l not required 6 days
5 8 Thal major post 
BMT
Fever, retro-orbital 
pain IgM positive 26x10
9/l 1.4x10
9/l not required 12 daysMediterr J Hematol Infect Dis 2011; 3: Open Journal System
prospectively, we did not find any increased morbidity 
or  mortality,  probably  because  of  transient  and 
temprorary effect  of  dengue  virus  on  bone  marrow, 
reflected by nearly complete recovery in all patients. 
Clinically, dengue presents with fever, bodyaches, 
joint  pains  and  bleeding  manifestations  in  form  of 
epistaxis, petechiae and gastrointestinal bleeding. All 
of the five patients had fever at presentation, though 
only  three  had  bleeding  manifestations.  Laboratory 
diagnosis of dengue depends on the clinical stage of 
the  patient.  In  the  early  stage  of  disease,  fever  and 
viremia  are  accompanied  by  NS1  (non  structural 
protein 1) antigens in the blood. After a week dengue 
specific IgM and IgG antibodies appear in the blood.
8
The  capture  ELISA  for  IgM  detection,  which  was 
performed in all patients, is the most useful serologic 
procedure  currently  available  and  it  is  widely 
recommended for serological surveillance.
9 There is no 
specific antiviral treatment or vaccine for dengue and 
the    patients  recovered  after  fluids  and  supportive 
therapy. 
Though our series had small number of cases, the 
detailed study of dengue infection in patients with pre-
existing hematological diseases gave us a new insight 
into the clinico-pathological impact of dengue in the 
clinical course of these diseases and the need to keep a 
high index of suspicion in diagnosis of such infections. 
Moreover, immunocompromised state did not seem to 
alter the clinical impact of dengue infection in patients 
with pre-existing hematological diseases. The serotype 
detected  was  dengue  virus  type  1,  which  causes  a 
milder form of infection.
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